|
US2385365A
(en)
|
1943-02-17 |
1945-09-25 |
Wisconsin Alumni Res Found |
Salicylic acid compounds for safer therapeutic use
|
|
US3939259A
(en)
|
1974-05-24 |
1976-02-17 |
Anthony Pescetti |
Coating composition and therapeutic preparation incorporating same
|
|
DE2537232B2
(de)
|
1974-08-22 |
1976-07-01 |
|
Spritz- und formmasse
|
|
US4374082A
(en)
|
1981-08-18 |
1983-02-15 |
Richard Hochschild |
Method for making a pharmaceutical and/or nutritional dosage form
|
|
ES2039226T3
(es)
|
1986-12-30 |
1993-09-16 |
American Cyanamid Company |
Procedimiento para preparar composiciones que contienen policarbofil.
|
|
US4758597A
(en)
|
1987-05-15 |
1988-07-19 |
University Patents, Inc. |
Carenadiol and derivatives
|
|
US4902513A
(en)
|
1987-07-31 |
1990-02-20 |
Jean Carvais |
Oral sustained release medicament
|
|
US5965162A
(en)
|
1993-09-10 |
1999-10-12 |
Fuisz Technologies Ltd. |
Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom
|
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
CN1151836C
(zh)
*
|
1995-03-31 |
2004-06-02 |
艾米斯菲尔技术有限公司 |
用作传送活性剂的化合物和组合物
|
|
EP1049474A4
(en)
|
1998-11-24 |
2004-12-29 |
Univ Connecticut |
CANNABIMIMETIC LIPID AMIDES FOR USE AS MEDICINES
|
|
JP2000256323A
(ja)
|
1999-01-08 |
2000-09-19 |
Japan Tobacco Inc |
２−オキソキノリン化合物及びその医薬用途
|
|
ES2235854T3
(es)
|
1999-04-05 |
2005-07-16 |
Emisphere Technologies, Inc. |
Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos.
|
|
US6495177B1
(en)
|
1999-08-13 |
2002-12-17 |
Warner Chilcott Laboratories Ireland Limited |
Orally dissolvable nutritional supplement
|
|
WO2001019901A2
(en)
|
1999-09-14 |
2001-03-22 |
Smithkline Beecham Corporation |
Process for making aqueous coated beadlets
|
|
GB0007419D0
(en)
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
|
EP1231273A1
(en)
|
2001-02-12 |
2002-08-14 |
Plant Research International B.V. |
Terpene synthase/cyclase and olefin synthase and uses thereof
|
|
GB2377633A
(en)
|
2001-05-11 |
2003-01-22 |
Gw Pharmaceuticals Ltd |
Pharmaceutical compositions comprising the cannabinoids THC and CBD
|
|
DK1361864T3
(en)
|
2001-02-14 |
2014-03-03 |
Gw Pharma Ltd |
FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
|
|
JP5026655B2
(ja)
|
2001-04-18 |
2012-09-12 |
プロメティック、バイオサイエンシーズ、インコーポレーテッド |
好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体
|
|
IL143318A0
(en)
|
2001-05-23 |
2002-04-21 |
Herbal Synthesis Corp |
Herbal compositions for the treatment of mucosal lesions
|
|
CA2466863A1
(en)
*
|
2001-11-29 |
2003-06-05 |
Emisphere Technologies, Inc. |
Oral pharmaceutical compositions comprising cromolyn sodium and an acylated amino acid
|
|
EP1492511B3
(fr)
|
2002-04-09 |
2012-05-02 |
Flamel Technologies |
Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
|
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
|
GB0222077D0
(en)
|
2002-09-23 |
2002-10-30 |
Gw Pharma Ltd |
Methods of preparing cannabinoids from plant material
|
|
CA2507815A1
(en)
|
2002-12-04 |
2004-06-17 |
Pharmos Corporation |
High enantiomeric purity dexanabinol for pharmaceutical compositions
|
|
AU2003301121A1
(en)
|
2002-12-18 |
2004-07-14 |
Pain Therapeutics, Inc. |
Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
|
|
AU2004296877A1
(en)
|
2003-12-09 |
2005-06-23 |
Incyte Corporation |
Dosing methods for ss-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
|
|
US20050191349A1
(en)
|
2003-12-31 |
2005-09-01 |
Garth Boehm |
Galantamine formulations
|
|
IL162636A0
(en)
|
2004-06-20 |
2005-11-20 |
Yissum Res Dev Co |
Resorcinol derivatives and their use for lowering blood pressure
|
|
CN101076324A
(zh)
|
2004-10-22 |
2007-11-21 |
法玛氏公司 |
口服有效的大麻素类似物
|
|
TWI360539B
(en)
|
2004-10-28 |
2012-03-21 |
Shionogi & Co |
3-carbamoyl-2-pyridone derivatives
|
|
GB0507167D0
(en)
|
2005-04-08 |
2005-05-18 |
Glaxosmithkline Consumer Healt |
Composition
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
EP1893753B1
(en)
|
2005-06-17 |
2015-12-23 |
Firmenich Sa |
Novel sesquiterpene synthases and methods of their use
|
|
US9125833B2
(en)
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
|
US20070104741A1
(en)
*
|
2005-11-07 |
2007-05-10 |
Murty Pharmaceuticals, Inc. |
Delivery of tetrahydrocannabinol
|
|
US9265724B2
(en)
|
2005-11-07 |
2016-02-23 |
Ram B. Murty |
Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
|
|
UY30090A1
(es)
|
2006-01-16 |
2007-08-31 |
Syngenta Participations Ag |
Insecticidas novedosos
|
|
US20070254911A1
(en)
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
|
WO2008024408A2
(en)
|
2006-08-22 |
2008-02-28 |
Theraquest Biosciences, Inc. |
Pharmaceutical formulations of cannabinoids for application to the skin and method of use
|
|
CA2662123C
(en)
|
2006-08-30 |
2015-12-01 |
Jagotec Ag |
Controlled release oral dosage formulations comprising a core and one or more barrier layers
|
|
GB0624340D0
(en)
|
2006-12-06 |
2007-01-17 |
Nature Therapeutics Ltd |
Antimicrobial composition
|
|
EP2139333A4
(en)
|
2007-03-28 |
2010-11-10 |
Merck Sharp & Dohme |
SUBSTITUTED PYRID- [3,2-E] - [1,2,4] -TRIAZOL- [4,3-C] -PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS
|
|
PL2215047T3
(pl)
|
2007-11-02 |
2014-05-30 |
Emisphere Tech Inc |
Sposób leczenia niedoborów witaminy b12
|
|
US20090155392A1
(en)
|
2007-12-17 |
2009-06-18 |
Bret David Nelson |
Methods and Systems for Sublingual Guarana Administration
|
|
WO2009100245A1
(en)
|
2008-02-05 |
2009-08-13 |
Emisphere Technologies Inc. |
Low dose hmg-coa reductase inhibitor with reduced side effects
|
|
US20110137040A1
(en)
|
2008-08-01 |
2011-06-09 |
Lange Josephus H M |
Synthesis of 3,4-diaryl-4,5-dihydro-(h)-pyrazole-1-carboxamidine derivatives
|
|
JP5740689B2
(ja)
|
2008-08-18 |
2015-06-24 |
エンテラ バイオ エルティーディー． |
タンパク質の経口投与用の方法および組成物
|
|
CN101439074B
(zh)
|
2008-12-11 |
2012-06-06 |
深圳海王药业有限公司 |
苍术总萜醇提取物及其制备方法和用途
|
|
CA2760460C
(en)
|
2009-04-28 |
2019-04-02 |
Alltranz Inc. |
Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same
|
|
CA2785056A1
(en)
|
2009-12-22 |
2011-07-21 |
Pondera Biotechnologies, LLC |
Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
|
|
SG190024A1
(en)
|
2010-11-25 |
2013-06-28 |
Aop Orphan Pharmaceuticals Ag |
Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
|
|
US20130224300A1
(en)
|
2011-08-26 |
2013-08-29 |
Edward T. Maggio |
Compositions and methods thereof for oral administration of drugs
|
|
ES2806034T3
(es)
|
2011-09-29 |
2021-02-16 |
Thc Pharm Gmbh The Health Concept |
Acidos carboxílicos de cannabinoide, sales de ácidos carboxílicos de cannabinoide, su preparación y aplicaciones
|
|
EP2601947A1
(en)
|
2011-12-05 |
2013-06-12 |
Abo Bakr Mohammed Ali Al-Mehdar |
Fixed-dose combination for treatment of helicobacter pylori associated diseases
|
|
US20150050373A1
(en)
|
2012-03-13 |
2015-02-19 |
Piramal Enterprises Limited |
Herbal composition for the treatment of metabolic disorders
|
|
WO2013165251A1
(en)
|
2012-05-03 |
2013-11-07 |
Echo Pharmaceuticals B.V. |
Cannabis plant isolate comprising /\9-tetrahydrocannabinol and a method for preparing such an isolate
|
|
EP2666461B1
(en)
|
2012-05-23 |
2015-07-01 |
Tergum S.L. |
Terpene extract for the treatment of hair loss
|
|
PL2897620T3
(pl)
|
2012-09-21 |
2020-11-02 |
Intensity Therapeutics, Inc |
Sposób leczenia nowotworu złośliwego
|
|
WO2014060472A1
(en)
|
2012-10-17 |
2014-04-24 |
Novo Nordisk A/S |
Fatty acid acylated amino acids for oral peptide delivery
|
|
US10639439B2
(en)
*
|
2013-01-30 |
2020-05-05 |
Midwest Pharmaceuticals, Llc |
Smokeless THC and administration method thereof
|
|
CA3012383C
(en)
|
2013-02-28 |
2021-03-02 |
Teewinot Technologies Limited |
Biosynthesis of cannabinoids
|
|
EP2968259B1
(en)
|
2013-03-14 |
2022-09-14 |
SC Laboratories Inc. |
Bioactive concentrates and uses thereof
|
|
MX2015011896A
(es)
|
2013-03-15 |
2016-07-19 |
Korea United Pharm Inc |
Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia.
|
|
JP6041823B2
(ja)
|
2013-03-16 |
2016-12-14 |
ファイザー・インク |
トファシチニブの経口持続放出剤形
|
|
US9326967B2
(en)
*
|
2013-08-22 |
2016-05-03 |
Stephen C. Perry |
Vaporizable cannabinoid compositions
|
|
US9532593B2
(en)
*
|
2013-12-26 |
2017-01-03 |
John Turner |
Herbal smoking blend
|
|
WO2015118549A1
(en)
|
2014-02-10 |
2015-08-13 |
F&C Licorice Ltd. |
Encapsulated biologically active agents
|
|
CA2845443A1
(en)
|
2014-03-04 |
2015-09-04 |
Pharmascience Inc. |
Orally disintegrating tablet of nabilone and method of manufacturing
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
WO2016022936A1
(en)
*
|
2014-08-07 |
2016-02-11 |
Murty Pharmaceuticals, Inc. |
An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts
|
|
US9375417B2
(en)
|
2014-12-04 |
2016-06-28 |
Mary's Medicinals LLC |
Transdermal cannabinoid formulations
|
|
AU2016225026A1
(en)
|
2015-02-27 |
2017-09-07 |
Canopy Growth Corporation |
Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
|
|
WO2016205923A1
(en)
|
2015-06-25 |
2016-12-29 |
Compressed Perforated Puck Technologies Inc. |
Ingestible plant source pill and method
|
|
BR112018071518A2
(pt)
|
2016-04-22 |
2019-02-19 |
Receptor Life Sciences, Inc. |
compostos medicinais à base de planta de ação rápida e suplementos nutricionais
|
|
EA201892396A1
(ru)
|
2016-12-02 |
2019-04-30 |
Ресептор Лайф Сайенсиз, Инк. |
Быстродействующие растительные лекарственные соединения и биологически активные добавки
|
|
US20190336472A1
(en)
|
2017-01-03 |
2019-11-07 |
Receptor Holdings, Inc. |
Medicinal compounds and nutritional supplements
|
|
AU2018233582B2
(en)
|
2017-03-16 |
2022-04-07 |
CannTab Therapeutics, Limited |
Modified release multi-layer tablet cannabinoid formulations
|
|
BR112019019776A2
(pt)
|
2017-03-23 |
2020-04-22 |
Receptor Holdings, Inc. |
entrega rápida e controlada de composições com efeitos entourage restaurados
|
|
JP2020536858A
(ja)
|
2017-10-05 |
2020-12-17 |
レセプター・ホールディングス・インコーポレイテッド |
改善されたバイオアベイラビリティーを有するハーブ組成物
|
|
CA3078549A1
(en)
|
2017-10-05 |
2019-04-11 |
Receptor Holdings, Inc. |
Rapid onset and extended action plant-based and synthetic cannabinoid formulations
|